Search Results - "Sanghavi, Maitri"
-
1
Physiologically Based Pharmacokinetics Modeling in Biopharmaceutics: Case Studies for Establishing the Bioequivalence Safe Space for Innovator and Generic Drugs
Published in Pharmaceutical research (01-02-2023)“…For successful oral drug development, defining a bioequivalence (BE) safe space is critical for the identification of newer bioequivalent formulations or for…”
Get full text
Journal Article -
2
Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications
Published in Biochemical pharmacology (01-02-2015)“…Growing body of evidence points out the crucial role of ACE2 in preventing atherosclerosis. However, data on how atherosclerosis affects ACE2 expression in…”
Get full text
Journal Article -
3
Role of Physiologically Based Biopharmaceutics Modeling (PBBM) in Fed Bioequivalence Study Waivers: Regulatory Outlook, Case Studies and Future Perspectives
Published in Journal of pharmaceutical sciences (01-02-2024)“…Over the past few decades, physiologically based biopharmaceutics modeling (PBBM) has demonstrated its utility in both new drug and generic product…”
Get more information
Journal Article -
4
NFAT inhibitor tributylhexadecylphosphoniumbromide, ameliorates high fructose induced insulin resistance and nephropathy
Published in Chemico-biological interactions (05-10-2015)“…High fructose diet (HFrD)-induced insulin resistance (IR) has been reported to be associated with an increase in albuminuria, glomerular hypertrophy and…”
Get full text
Journal Article -
5
PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report
Published in Molecular pharmaceutics (04-11-2024)“…The proceedings from the 30th August 2023 (Day 2) of the workshop “Physiologically Based Biopharmaceutics Models (PBBM) Best Practices for Drug Product…”
Get full text
Journal Article